Literature DB >> 17190457

Cytotoxic flavaglines and bisamides from Aglaia edulis.

Soyoung Kim1, Young-Won Chin, Bao-Ning Su, Soedarsono Riswan, Leonardus B S Kardono, Johar J Afriastini, Heebyung Chai, Norman R Farnsworth, Geoffrey A Cordell, Steven M Swanson, A Douglas Kinghorn.   

Abstract

Two new cyclopenta[b]benzofurans, aglaroxin A 1-O-acetate (2) and 3'-methoxyaglaroxin A 1-O-acetate (3), a new benzo[b]oxepine, 19,20-dehydroedulisone A (4), and five new cyclopenta[bc]benzopyrans, edulirin A (5), edulirin A 10-O-acetate (6), 19,20-dehydroedulirin A (7), isoedulirin A (8), and edulirin B (9), were isolated from the bark of Aglaia edulis, along with one known cyclopenta[b]benzofuran, aglaroxin A (1). Additionally, four new amides, aglamides A-D (10-13), as well as three known compounds, aglalactone, scopoletin, and 5-hydroxy-3,6,7,4'-tetramethoxyflavone, were isolated from the leaves and/or twigs of this species. The structures of the new compounds (2-13) were elucidated by interpretation of their spectroscopic data. All isolates obtained in this study were evaluated for cytotoxicity against both several human cancer cell lines (Lu1, LNCaP, and MCF-7) and a nontumorigenic (HUVEC) cell line. Among these isolates, the cyclopenta[b]benzofurans (1-3) exhibited potent in vitro cytotoxic activity (ED50 range 0.001 to 0.8 microg/mL). Aglaroxin A 1-O-acetate (2) was further evaluated in the in vivo P388 lymphocytic leukemia model, by intraperitoneal injection, but found to be inactive in this model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190457      PMCID: PMC2471874          DOI: 10.1021/np060428x

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  25 in total

1.  Cytotoxic constituents from leaves of Aglaia elliptifolia.

Authors:  S K Wang; Y J Cheng; C Y Duh
Journal:  J Nat Prod       Date:  2001-01       Impact factor: 4.050

2.  Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal.

Authors:  M E Wall; M C Wani; D M Brown; F Fullas; J B Olwald; F F Josephson; N M Thornton; J M Pezzuto; C W Beecher; N R Farnsworth; G A Cordell; A D Kinghorn
Journal:  Phytomedicine       Date:  1996-11       Impact factor: 5.340

3.  Diamide derivatives and cycloartanes from the leaves of Aglaia elliptica.

Authors:  A Inada; T Sorano; H Murata; Y Inatomi; D Darnaedi; T Nakanishi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2001-09       Impact factor: 1.645

4.  Cytotoxic and antiplatelet aggregation principles from Aglaia elliptifolia.

Authors:  T S Wu; M J Liou; C S Kuoh; C M Teng; T Nagao; K H Lee
Journal:  J Nat Prod       Date:  1997-06       Impact factor: 4.050

5.  Rocaglamides, glycosides, and putrescine bisamides from Aglaia dasyclada.

Authors:  W H Lin; R Ebel; R A Edrada; V Wray; M Nimtz; W Sumaryono; P Proksch
Journal:  J Nat Prod       Date:  2001-09       Impact factor: 4.050

6.  Flavonol-cinnamate cycloadducts and diamide derivatives from Aglaia laxiflora.

Authors:  Y J Xu; X H Wu; B K Tan; Y H Lai; J J Vittal; Z Imiyabir; L Madani; K S Khozirah; S H Goh
Journal:  J Nat Prod       Date:  2000-04       Impact factor: 4.050

7.  Cyclopentabenzofuran lignan protein synthesis inhibitors from Aglaia odorata.

Authors:  T Ohse; S Ohba; T Yamamoto; T Koyano; K Umezawa
Journal:  J Nat Prod       Date:  1996-07       Impact factor: 4.050

8.  Insecticidal flavaglines and other compounds from Fijian Aglaia species.

Authors:  H Grege; T Pache; B Brem; M Bacher; O Hofer
Journal:  Phytochemistry       Date:  2001-05       Impact factor: 4.072

Review 9.  Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy.

Authors:  Soyoung Kim; Angela A Salim; Steven M Swanson; A Douglas Kinghorn
Journal:  Anticancer Agents Med Chem       Date:  2006-07       Impact factor: 2.505

10.  Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.

Authors:  Bang Yeon Hwang; Bao-Ning Su; Heebyung Chai; Qiuwen Mi; Leonardus B S Kardono; Johar J Afriastini; Soedarsono Riswan; Bernard D Santarsiero; Andrew D Mesecar; Robert Wild; Craig R Fairchild; Gregory D Vite; William C Rose; Norman R Farnsworth; Geoffrey A Cordell; John M Pezzuto; Steven M Swanson; A Douglas Kinghorn
Journal:  J Org Chem       Date:  2004-05-14       Impact factor: 4.354

View more
  8 in total

Review 1.  Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae).

Authors:  Sherif S Ebada; Neil Lajkiewicz; John A Porco; Min Li-Weber; Peter Proksch
Journal:  Prog Chem Org Nat Prod       Date:  2011

Review 2.  The relevance of higher plants in lead compound discovery programs.

Authors:  A Douglas Kinghorn; Li Pan; Joshua N Fletcher; Heebyung Chai
Journal:  J Nat Prod       Date:  2011-06-08       Impact factor: 4.050

Review 3.  Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.

Authors:  Li Pan; John L Woodard; David M Lucas; James R Fuchs; A Douglas Kinghorn
Journal:  Nat Prod Rep       Date:  2014-05-02       Impact factor: 13.423

4.  Constituents of the Leaves and Stem Bark of Aglaia foveolata.

Authors:  Angela A Salim; Hee-Byung Chai; Ismail Rachman; Soedarsono Riswan; Leonardus B S Kardono; Norman R Farnsworth; Esperanza J Carcache-Blanco; A Douglas Kinghorn
Journal:  Tetrahedron       Date:  2007-08-13       Impact factor: 2.457

5.  Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.

Authors:  Marie-Eve Bordeleau; Francis Robert; Baudouin Gerard; Lisa Lindqvist; Samuel M H Chen; Hans-Guido Wendel; Brigitte Brem; Harald Greger; Scott W Lowe; John A Porco; Jerry Pelletier
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

6.  Cytotoxic and Apoptotic Activity of Aglaforbesin Derivative Isolated from Aglaia loheri Merr. on HCT116 Human Colorectal Cancer Cells.

Authors:  Norielyn N Abalos; Virgilio D Ebajo; Drexel H Camacho; Sonia D Jacinto
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

Review 7.  The value of universally available raw NMR data for transparency, reproducibility, and integrity in natural product research.

Authors:  James B McAlpine; Shao-Nong Chen; Andrei Kutateladze; John B MacMillan; Giovanni Appendino; Andersson Barison; Mehdi A Beniddir; Maique W Biavatti; Stefan Bluml; Asmaa Boufridi; Mark S Butler; Robert J Capon; Young H Choi; David Coppage; Phillip Crews; Michael T Crimmins; Marie Csete; Pradeep Dewapriya; Joseph M Egan; Mary J Garson; Grégory Genta-Jouve; William H Gerwick; Harald Gross; Mary Kay Harper; Precilia Hermanto; James M Hook; Luke Hunter; Damien Jeannerat; Nai-Yun Ji; Tyler A Johnson; David G I Kingston; Hiroyuki Koshino; Hsiau-Wei Lee; Guy Lewin; Jie Li; Roger G Linington; Miaomiao Liu; Kerry L McPhail; Tadeusz F Molinski; Bradley S Moore; Joo-Won Nam; Ram P Neupane; Matthias Niemitz; Jean-Marc Nuzillard; Nicholas H Oberlies; Fernanda M M Ocampos; Guohui Pan; Ronald J Quinn; D Sai Reddy; Jean-Hugues Renault; José Rivera-Chávez; Wolfgang Robien; Carla M Saunders; Thomas J Schmidt; Christoph Seger; Ben Shen; Christoph Steinbeck; Hermann Stuppner; Sonja Sturm; Orazio Taglialatela-Scafati; Dean J Tantillo; Robert Verpoorte; Bin-Gui Wang; Craig M Williams; Philip G Williams; Julien Wist; Jian-Min Yue; Chen Zhang; Zhengren Xu; Charlotte Simmler; David C Lankin; Jonathan Bisson; Guido F Pauli
Journal:  Nat Prod Rep       Date:  2018-07-13       Impact factor: 13.423

8.  A phenolic ester from Aglaia loheri leaves reveals cytotoxicity towards sensitive and multidrug-resistant cancer cells.

Authors:  Else Dapat; Sonia Jacinto; Thomas Efferth
Journal:  BMC Complement Altern Med       Date:  2013-10-27       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.